This post was originally published on this site
Original post: Newswise - Drug and Drug Abuse Age-Related Differences in Inflammation May Shed Light on the Limit of Immunotherapies
Scientists at the Sbarro Institute for Cancer Research and Molecular Medicine, Center of Biotechnology, located at Temple University’s College of Science and Technology, working with collaborators in Italy, have described the age-related differences in inflammatory response to an emerging immunotherapy treatment for Non-Small-Cell Lung Cancer (NSCLC) called PD-1 blockade.